Search Results - "MADORE, D"

Refine Results
  1. 1

    Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants by Rennels, Margaret B, Edwards, Kathryn M, Keyserling, Harry L, Reisinger, Keith S, Hogerman, Deborah A, Madore, Dace V, Chang, Ih, Paradiso, Peter R, Malinoski, Frank J, Kimura, Alan

    Published in Pediatrics (Evanston) (01-04-1998)
    “…To determine the safety and immunogenicity of heptavalent pneumococcal saccharide vaccine (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) individually conjugated to…”
    Get full text
    Journal Article
  2. 2

    Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S by Quataert, S A, Kirch, C S, Wiedl, L J, Phipps, D C, Strohmeyer, S, Cimino, C O, Skuse, J, Madore, D V

    “…A human reference serum pool, lot 89-S, has been developed for use in quantitating concentrations of antibody to Streptococcus pneumoniae. Weight-based units…”
    Get full text
    Journal Article
  3. 3

    An Analytical Model Applied to a Multicenter Pneumococcal Enzyme-Linked Immunosorbent Assay Study by PLIKAYTIS, B. D, GOLDBLATT, D, NAHM, M. H, SCHULMAN, C. A, HOLDER, P. F, LEZHAVA, T, ELIE, C. M, CARLONE, G. M, FRASCH, C. E, BLONDEAU, C, BYBEL, M. J, GIEBINK, G. S, JONSDOTTIR, I, KÄYHTY, H, KONRADSEN, H. B, MADORE, D. V

    Published in Journal of Clinical Microbiology (01-06-2000)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4

    Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody by Yang, D.P., Zielinska, E., Quiroz, J., Madore, D., Rappaport, R.

    Published in Biologicals (01-06-2007)
    “…Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infection in infants, young children and the elderly. Yet, the development of a…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies by Jansen, W T, Gootjes, J, Zelle, M, Madore, D V, Verhoef, J, Snippe, H, Verheul, A F

    “…A phagocytosis assay for Streptococcus pneumoniae based on flow cytometry (FACS) with human polymorphonuclear cells and human complement was developed for the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Mechanism of Antibody-Mediated Reduction of Nasopharyngeal Colonization by Haemophilus influenzae Type b Studied in an Infant Rat Model by Kauppi-Korkeila, Maija, van Alphen, Loek, Madore, Dace, Saarinen, Leena, Käyhty, Helena

    Published in The Journal of infectious diseases (01-12-1996)
    “…The mechanism of antibody-mediated reduction of Haemophilus influenzae type b (Hib) carriage was studied in the infant rat colonization model. Monoclonal Hib…”
    Get full text
    Journal Article
  9. 9

    Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants by PARADISO, P. R, HOGERMAN, D. A, MADORE, D. V, KEYSERLING, H, KING, J, REISINGER, K. S, BLATTER, M. M, ROTHSTEIN, E, BERNSTEIN, H. H, HACKELL, J

    Published in Pediatrics (Evanston) (01-12-1993)
    “…To study the safety and immunogenicity of a combined diphtheria-tetanus-pertussis (DTP)-Haemophilus influenzae type b (HbOC) vaccine (TETRAMUNE) in infants as…”
    Get full text
    Journal Article
  10. 10

    A MULTI-LABORATORY EVALUATION OF AN ENZYME-LINKED IMMUNOASSAY QUANTITATING HUMAN ANTIBODIES TO STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES by Quataert, S., Martin, D., Anderson, P., Giebink, G. S., Henrichsen, J., Leinonen, M., Granoff, D. M., Russell, H., Siber, G., Faden, H., Barnes, D., Madore, D. V.

    Published in Immunological investigations (01-01-2001)
    “…An enzyme-linked immunoassay (EIA) is described and evaluated which quantitates human antibodies to serotype specific S. pneumoniae polysaccharide (PnPs) in…”
    Get full text
    Journal Article
  11. 11

    Characterization of immune response as an indicator of Haemophilus influenzae type b vaccine efficacy by MADORE, DACE V

    Published in The Pediatric infectious disease journal (01-09-1998)
    “…Quantitation of antibodies to Haemophilus influenzae type b (Hib) polysaccharide has been an active area of investigation associated with the development of…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Kinetics of Antibody Response to Haemophilus influenzae Type b Vaccines by Madore, D. V., Johnson-Kraines, C. L., Rothstein, E. P., Smith, D. H.

    “…Summary Serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b (Hib) are effective in preventing or ameliorating invasive disease…”
    Get full text
    Journal Article
  13. 13

    An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay by Phipps, D C, West, J, Eby, R, Koster, M, Madore, D V, Quataert, S A

    Published in Journal of immunological methods (31-12-1990)
    “…An ELISA measuring total Ig antibodies to the capsular polysaccharide of Haemophilus influenzae type b (HbPs) in human sera using an antigen composed of…”
    Get more information
    Journal Article
  14. 14

    Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine by Huebner, Robin E, Mbelle, Nontombi, Forrest, Bruce, Madore, Dace V, Klugman, Keith P

    Published in Vaccine (29-07-2004)
    “…Children who had initially received three doses of either a nonavalent pneumococcal conjugate vaccine containing serotypes 1, 4, 5, 6B, 9V, 14, 18C, 19F, and…”
    Get full text
    Journal Article
  15. 15

    A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics by Steinhoff, M C, Edwards, K, Keyserling, H, Thoms, M L, Johnson, C, Madore, D, Hogerman, D

    Published in The Pediatric infectious disease journal (01-05-1994)
    “…Because most childhood invasive pneumococcal disease occurs before the age of 2 years, the development of a pneumococcal vaccine that is immunogenic in infants…”
    Get more information
    Journal Article
  16. 16

    Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay by Madore, D V, Anderson, P, Baxter, B D, Carlone, G M, Edwards, K M, Hamilton, R G, Holder, P, Käyhty, H, Phipps, D C, Peeters, C C, Schneerson, R, Siber, G R, Ward, J I, Frasch, C E

    “…An interlaboratory study was conducted to determine whether an enzyme-linked immunosorbent assay (ELISA) with an antigen preparation composed of various-sized…”
    Get full text
    Journal Article
  17. 17

    Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines by Sikkema, D J, Friedman, K E, Corsaro, B, Kimura, A, Hildreth, S W, Madore, D V, Quataert, S A

    “…A new meningococcal group C-CRM(197) conjugate vaccine (MnCC; Meningitec) has been evaluated in multiple clinical trials in the United States and most recently…”
    Get full text
    Journal Article
  18. 18

    Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy by Esposito, Susanna, Madore, Dace V., Gironi, Stefania, Bosis, Samantha, Tosi, Silvia, Bianchi, Ciro, Cimino, Carolyn, Principi, Nicola

    Published in Vaccine (20-06-2003)
    “…In order to evaluate the theoretic coverage of the heptavalent conjugate vaccine against community-acquired pneumonia (CAP) during the first years of life, the…”
    Get full text
    Journal Article
  19. 19

    Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants by Madore, D V, Johnson, C L, Phipps, D C, Popejoy, L A, Eby, R, Smith, D H

    Published in Pediatrics (Evanston) (01-03-1990)
    “…A Haemophilus influenzae type b oligosaccharide-CRM197 conjugate (HbOC) vaccine was evaluated for safety and immunogenicity in 432 infants 1 to 6 months of…”
    Get full text
    Journal Article
  20. 20